China Widens Probe of Sexual Bribes and Glaxo Execs

China Widens Probe of Sexual Bribes and Glaxo Execs Play

July 16 (Bloomberg) -- China is investigating at least four multinational drugmakers as it widens its probe of GlaxoSmithKline Plc, according to a lawyer in Hong Kong whose firm advises companies on cross-border anti-corruption. Olivia Sterns reports on Bloomberg Television's "Market Makers." (Source: Bloomberg)

  • On Air Now

    The Year Ahead: Innovation Watch Now

  • Next

    Bloomberg West

blog comments powered by Disqus